Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24945,877,1.00 [0.88-1.13],0.983669349654286
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24971,132,1.17 [0.86-1.59],0.3084684460872667
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26507,148,1.07 [0.80-1.43],0.656879996205018
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19830,479,1.16 [0.98-1.36],0.0878087475582072
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26446,87,0.89 [0.60-1.33],0.582456966582843
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25756,76,0.92 [0.60-1.41],0.6972842504951999
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27460,86,0.90 [0.61-1.34],0.6137229070075348
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27480,60,0.81 [0.50-1.31],0.3896603438383664
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25216,46,1.38 [0.84-2.27],0.2005258496602968
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26960,100,0.90 [0.62-1.30],0.5593424519255633
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26926,66,0.90 [0.57-1.43],0.6627118811833446
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27522,65,1.06 [0.68-1.65],0.8070520032355859
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27481,96,1.02 [0.70-1.47],0.9363852102663496
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27472,87,1.01 [0.69-1.48],0.9682453982581736
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Mycoses,27293,43,0.99 [0.57-1.72],0.9653605311001108
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26677,383,1.06 [0.88-1.27],0.5449907801102574
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26438,144,1.10 [0.82-1.48],0.5232782658797286
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26540,246,1.07 [0.85-1.34],0.5893661568595232
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",23901,30,0.93 [0.47-1.83],0.8394068747346891
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",23919,48,0.79 [0.46-1.35],0.38675514620946
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23997,126,0.98 [0.71-1.36],0.9077509575158668
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24002,131,1.01 [0.74-1.39],0.9391005388513184
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13438,281,0.93 [0.74-1.16],0.4963278261491004
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",10741,27,1.57 [0.86-2.86],0.1394687170598226
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",23920,49,0.95 [0.56-1.60],0.8382518473315053
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,25433,798,1.09 [0.96-1.24],0.173567055780354
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26475,196,1.11 [0.86-1.43],0.4226895438522365
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27110,77,0.88 [0.58-1.35],0.5670982282912933
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27592,71,0.86 [0.55-1.34],0.5050772831973708
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Rectum,27361,47,1.92 [1.25-2.96],0.0030776558695118
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27600,38,0.97 [0.54-1.77],0.9323501364788664
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Stomach,27639,31,1.06 [0.56-2.01],0.8635705160116598
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm,27334,290,1.05 [0.85-1.29],0.6617038942258138
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27570,113,1.06 [0.76-1.48],0.7291345998088123
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27574,94,1.03 [0.71-1.50],0.858644637161461
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27540,43,1.01 [0.59-1.75],0.9606620312309986
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma, any site",27542,43,1.01 [0.59-1.75],0.9605093859242002
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi,27437,242,1.05 [0.83-1.31],0.7048384626606707
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27599,111,1.20 [0.87-1.67],0.2612147733100556
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Other benign neoplasms of skin,27514,186,0.80 [0.61-1.06],0.117933002723281
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of breast,15256,94,0.96 [0.66-1.41],0.8463343626865982
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Leiomyoma of uterus,14899,680,1.01 [0.88-1.17],0.8683755162673273
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26633,195,1.29 [1.01-1.65],0.0378168089129978
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26530,347,1.06 [0.87-1.28],0.5715410965959267
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26530,347,1.06 [0.87-1.28],0.5715410965959267
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),25326,348,1.35 [1.13-1.62],0.0011592047326067
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27178,79,0.76 [0.50-1.17],0.2104607221291631
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27380,104,1.23 [0.88-1.72],0.2330937275052769
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24240,688,1.23 [1.07-1.41],0.003372233558729
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26342,432,1.00 [0.84-1.19],0.9732641416950242
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25863,114,1.12 [0.81-1.56],0.4831459657855094
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26895,54,0.96 [0.58-1.58],0.8620651962184971
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25848,99,1.21 [0.86-1.71],0.2746601428562686
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26072,323,1.10 [0.90-1.35],0.3590216217638835
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26063,314,1.09 [0.89-1.34],0.4124719356411096
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25719,178,0.87 [0.64-1.18],0.3679919630081216
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25724,176,0.89 [0.66-1.21],0.4509648201300903
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24079,527,1.23 [1.05-1.43],0.0110124922616049
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",23625,73,1.29 [0.86-1.94],0.2134336984413777
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24035,483,1.23 [1.04-1.44],0.0143321224329042
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23593,41,1.59 [0.96-2.63],0.0700079401511822
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23630,78,1.06 [0.71-1.59],0.7766320821407813
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,23976,754,1.08 [0.94-1.23],0.2820581530589924
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23512,290,1.08 [0.87-1.33],0.5107445718923123
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27202,222,0.96 [0.75-1.23],0.7380645952674633
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27271,158,1.00 [0.75-1.34],0.993515887381039
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,25673,81,0.88 [0.58-1.33],0.5376161772573863
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27521,81,0.84 [0.56-1.28],0.4252739843724011
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23303,81,0.88 [0.58-1.32],0.5306729989484983
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Alcohol dependence,25687,95,0.91 [0.62-1.34],0.6419306893147597
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,25653,66,1.65 [1.11-2.47],0.0142172186226889
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23293,71,0.81 [0.51-1.26],0.3495165406023464
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23605,383,1.00 [0.83-1.20],0.9783963938305276
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Depression,25932,332,1.00 [0.82-1.22],0.998015180625632
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Depression or dysthymia,23455,289,1.04 [0.84-1.29],0.6878848265886152
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23366,144,1.20 [0.90-1.60],0.2249700692575779
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Other anxiety disorders,26152,69,0.94 [0.60-1.46],0.7785767459532438
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Neurological diseases,24594,1430,1.12 [1.02-1.24],0.0180296587544342
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22925,157,1.07 [0.81-1.43],0.6286267279813982
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27437,127,1.15 [0.84-1.56],0.3841252622197728
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26314,489,1.09 [0.92-1.28],0.3178466058192573
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Epilepsy,25992,167,0.99 [0.75-1.31],0.9338859016959312
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Migraine,25928,103,1.13 [0.80-1.60],0.4877410800878452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27269,94,1.13 [0.79-1.62],0.5108971393406561
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27155,39,0.96 [0.54-1.72],0.9028363483078804
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other sleep disorders,25996,171,1.17 [0.89-1.53],0.2655110749747974
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Sleep apnoea,27037,133,1.12 [0.82-1.53],0.4680023048649095
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26533,610,1.12 [0.97-1.30],0.1114091455786534
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26058,135,1.38 [1.04-1.84],0.0274740317897764
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26252,329,0.98 [0.80-1.20],0.8562669642006917
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27424,84,0.94 [0.63-1.40],0.7648982918827856
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hemiplegia,27393,53,0.94 [0.56-1.56],0.8048772855774882
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other neurological diseases,27211,121,0.93 [0.67-1.30],0.6777783179385746
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27176,312,1.05 [0.85-1.28],0.6623627113027697
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27033,169,1.11 [0.85-1.46],0.4423394116111492
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26951,87,0.88 [0.59-1.31],0.5284636900497839
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26967,103,1.05 [0.74-1.50],0.766260669086815
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26915,51,1.35 [0.85-2.15],0.2043429350652804
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25954,66,1.39 [0.92-2.11],0.1186406964573727
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26073,185,1.21 [0.94-1.56],0.1460442582029106
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27031,129,1.19 [0.87-1.61],0.2757694543268332
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27388,25,2.09 [1.18-3.69],0.0110455132813116
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1716,25,1.82 [0.96-3.45],0.0679077826631699
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25697,25,2.11 [1.20-3.72],0.0094576188289005
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27265,49,1.37 [0.85-2.21],0.1979096595673043
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27245,29,1.57 [0.87-2.84],0.1368067299499133
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27178,93,1.05 [0.72-1.51],0.8042184782972284
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27219,96,0.97 [0.67-1.40],0.8517818453965089
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27516,122,1.08 [0.78-1.49],0.6456931553268606
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27123,92,1.12 [0.78-1.61],0.5396364248529055
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21651,1944,1.16 [1.07-1.27],0.0006492213380901
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27316,40,0.60 [0.32-1.11],0.1041211457415187
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22689,1296,1.17 [1.05-1.30],0.0033214823761563
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,22713,1320,1.17 [1.05-1.30],0.0035150501706767
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21441,48,1.13 [0.68-1.88],0.6424291362758366
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26149,563,1.03 [0.88-1.20],0.7157173003703399
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Angina pectoris,25933,347,0.98 [0.81-1.20],0.8528700093878414
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26932,135,0.93 [0.68-1.27],0.6337203081276352
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27053,256,0.97 [0.77-1.22],0.7828263878671519
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27533,56,0.89 [0.54-1.47],0.6549862858892508
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25742,156,1.01 [0.76-1.35],0.943760000857327
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25994,418,1.03 [0.86-1.23],0.7752316725862932
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27125,79,0.97 [0.65-1.46],0.8849927713520089
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27117,175,0.87 [0.66-1.15],0.3417593565944844
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27107,61,1.03 [0.65-1.63],0.8958264359191889
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27108,62,1.04 [0.66-1.64],0.8716126316186044
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21452,59,1.06 [0.67-1.69],0.8034450494020655
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25054,46,1.08 [0.64-1.83],0.76499152745134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Conduction disorders,25080,72,1.15 [0.76-1.73],0.5101185466501982
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,18894,91,1.51 [1.08-2.11],0.0154866270937137
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18991,188,1.05 [0.81-1.36],0.713394487443462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arrhythmias,25048,40,1.36 [0.81-2.30],0.2448539050883154
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25069,61,0.96 [0.60-1.53],0.8673227934720683
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27144,119,1.19 [0.86-1.64],0.2936545305834986
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27108,112,1.12 [0.80-1.56],0.5060500327042943
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27140,83,1.19 [0.81-1.74],0.3683247453033472
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27188,72,1.19 [0.79-1.79],0.407655143401039
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26917,50,1.12 [0.67-1.85],0.6689352483859694
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26950,83,1.13 [0.77-1.67],0.5232292586547836
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26417,115,0.97 [0.70-1.36],0.8737633674198791
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26397,95,1.03 [0.72-1.49],0.8599554572513831
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27472,91,1.06 [0.73-1.54],0.7413920520447015
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Varicose veins,26732,430,0.79 [0.66-0.95],0.0127438500701812
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypotension,26909,55,1.11 [0.69-1.78],0.6794761355005301
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,23406,1902,1.08 [0.99-1.17],0.094828891415995
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27414,135,1.21 [0.90-1.63],0.2157724682929578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26459,184,1.28 [0.99-1.64],0.0587081320563886
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26433,158,1.24 [0.94-1.63],0.129955119664349
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27044,207,1.05 [0.82-1.35],0.6960443143594268
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27042,205,1.05 [0.82-1.35],0.7032353072123387
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26763,652,0.99 [0.86-1.14],0.8826062901709494
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic sinusitis,26203,92,1.30 [0.91-1.85],0.1445563741267407
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Nasal polyp,26219,108,1.11 [0.79-1.56],0.5394536087439115
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26528,417,0.97 [0.81-1.16],0.7565900420205823
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Deviated nasal septum,26332,221,1.00 [0.79-1.28],0.9858201354363748
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,15928,50,0.59 [0.33-1.03],0.0626570980568626
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25311,856,0.96 [0.84-1.08],0.4813313960776086
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Early onset COPD,26931,104,0.78 [0.54-1.15],0.209101102007452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26931,104,0.78 [0.54-1.15],0.209101102007452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26931,104,0.78 [0.54-1.15],0.209101102007452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25911,779,0.94 [0.82-1.07],0.3523874545902947
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Asthma,21172,779,0.97 [0.84-1.10],0.6003722176802972
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21033,779,0.96 [0.84-1.10],0.5738978327756719
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21157,764,0.95 [0.83-1.09],0.4479692251775085
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27454,55,1.01 [0.62-1.65],0.958632349448178
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Interstitial lung disease,26334,42,0.78 [0.43-1.40],0.4009412186430832
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27514,42,0.78 [0.43-1.40],0.4060956990863045
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26327,35,0.67 [0.35-1.29],0.2298073458550168
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural effusion,26322,75,1.28 [0.87-1.90],0.2163337215192768
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of pleura,26424,177,1.28 [0.99-1.65],0.0642294360681846
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26809,83,1.46 [1.02-2.11],0.039660889940719
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19573,5063,1.07 [1.01-1.14],0.0254049793351133
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27046,491,1.03 [0.87-1.21],0.7586946882424983
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27569,141,1.06 [0.79-1.43],0.701098640446566
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impacted teeth,27575,132,1.10 [0.81-1.49],0.5433861042072484
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Dental caries,26676,121,1.06 [0.77-1.47],0.7109261194538695
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26661,106,1.12 [0.79-1.57],0.5220068655066101
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27555,156,1.08 [0.81-1.43],0.6109964915635853
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26648,93,1.15 [0.80-1.65],0.4481761675189086
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26397,65,1.15 [0.75-1.77],0.5218962502620744
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27517,45,0.95 [0.55-1.64],0.8637579544010285
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22233,198,1.00 [0.77-1.29],0.9828282403050544
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23753,1718,1.08 [0.99-1.18],0.0958322673060658
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophagitis,22300,265,1.18 [0.95-1.47],0.1289526037727058
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,22582,547,0.99 [0.85-1.16],0.8857448724838329
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22101,66,1.28 [0.84-1.95],0.2522016073383042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22164,129,1.23 [0.90-1.66],0.1907842575370237
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22067,32,0.79 [0.40-1.54],0.488941269273724
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastric ulcer,22136,101,0.88 [0.61-1.27],0.4968132597750787
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Duodenal ulcer,22134,99,1.08 [0.75-1.54],0.6900107857815283
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27535,70,0.96 [0.62-1.49],0.8589556177202446
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic gastritis,22136,101,0.98 [0.68-1.41],0.9180432519821088
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22665,630,1.17 [1.01-1.35],0.0319805779669912
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of appendix,27448,159,1.10 [0.83-1.45],0.5253033191494153
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Functional dyspepsia,22415,380,1.06 [0.88-1.27],0.568247783000116
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22151,116,1.10 [0.80-1.53],0.5486918381571834
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27441,184,0.99 [0.76-1.29],0.9268483830219624
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute appendicitis,27413,124,1.03 [0.75-1.42],0.8439584921369235
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Hernia,24914,1155,1.11 [1.00-1.24],0.0505585369107069
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Inguinal hernia,24147,388,1.08 [0.90-1.30],0.3997474243641894
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Umbilical hernia,23877,118,1.26 [0.92-1.72],0.1550155065936758
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ventral hernia,23854,95,1.01 [0.70-1.46],0.9637167732336476
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24345,586,1.16 [1.00-1.34],0.0508770364001065
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26766,741,1.17 [1.03-1.33],0.0191279547503494
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestines,22752,1641,1.04 [0.95-1.14],0.4146264316373976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27305,70,1.08 [0.70-1.64],0.7365931919553348
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27553,100,1.14 [0.80-1.61],0.4672867846342473
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn disease,26125,100,1.15 [0.81-1.62],0.4437803457815154
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26101,76,1.12 [0.75-1.67],0.5921197410433123
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27505,133,1.03 [0.76-1.41],0.8403921944640422
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcerative colitis,26158,133,1.04 [0.76-1.41],0.8159360901803923
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26140,115,1.03 [0.74-1.43],0.8737425750839547
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26614,589,1.23 [1.06-1.41],0.0054738820887342
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26609,584,1.23 [1.06-1.42],0.0048526934594338
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21181,70,1.23 [0.81-1.85],0.3268991046924071
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal stricture,27303,70,1.22 [0.81-1.85],0.3337889844118183
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21159,48,1.16 [0.70-1.91],0.5618486845335474
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,21407,296,0.95 [0.76-1.17],0.6065947422691139
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21285,174,1.11 [0.85-1.45],0.4356863662628168
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21358,247,1.26 [1.02-1.57],0.0343703499508297
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Constipation,26478,221,1.26 [1.00-1.58],0.0505069609828656
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27226,83,1.05 [0.71-1.56],0.7904717850785006
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21285,174,0.99 [0.75-1.30],0.9301161555989178
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21196,85,0.96 [0.65-1.43],0.8547261522637587
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,21886,775,1.03 [0.90-1.17],0.6545169832619606
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestine,21289,178,1.03 [0.79-1.34],0.8412228189421463
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27214,71,0.95 [0.62-1.45],0.7995922537641749
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of liver,26904,118,0.84 [0.59-1.18],0.3160131277513274
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of liver,26851,65,0.73 [0.45-1.17],0.1923533524406938
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26417,513,1.08 [0.92-1.26],0.3609576755136878
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholelithiasis,26310,406,1.10 [0.92-1.32],0.2749698972528609
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholecystitis,25981,77,1.22 [0.82-1.79],0.3260915577696982
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25947,43,0.92 [0.53-1.61],0.7745139974031217
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis,25963,59,0.90 [0.55-1.46],0.6669523450623385
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27474,59,0.90 [0.55-1.46],0.6578145835626956
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26395,275,1.21 [0.98-1.50],0.069844747951273
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26185,65,1.24 [0.81-1.89],0.3288855471594019
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Coeliac disease,26171,51,1.13 [0.69-1.85],0.6307880997002966
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26161,41,1.41 [0.84-2.36],0.1921342025844998
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26296,176,1.18 [0.91-1.54],0.2078143679527151
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,GI-bleeding,26291,171,1.17 [0.90-1.54],0.2418641193979572
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25067,1469,0.98 [0.89-1.09],0.7570604238549667
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27258,99,0.96 [0.67-1.39],0.8373797883992158
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27206,461,1.02 [0.86-1.21],0.8193234676825871
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26542,528,0.94 [0.80-1.10],0.4302672508847187
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26864,388,1.02 [0.85-1.22],0.8581545162696043
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26580,104,0.98 [0.69-1.40],0.9187736520650658
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26695,219,1.01 [0.79-1.28],0.9559299900071186
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27383,85,1.00 [0.68-1.47],0.9866224625477602
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27369,71,0.94 [0.61-1.45],0.7823374277429064
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27348,50,0.97 [0.58-1.61],0.9000171303794284
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27467,33,0.70 [0.36-1.36],0.2878273401751202
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27464,30,0.70 [0.35-1.40],0.3080312960764316
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26807,62,1.15 [0.74-1.79],0.5317306982497191
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27097,352,1.02 [0.84-1.23],0.8677507113642915
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26083,69,0.82 [0.52-1.29],0.3931228901675605
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26111,97,0.77 [0.53-1.14],0.1918182578598291
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26096,82,0.74 [0.49-1.13],0.1620794267159018
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26223,209,0.92 [0.72-1.19],0.5442907871350968
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26194,180,0.83 [0.63-1.10],0.1972381707179418
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21400,3454,1.06 [0.99-1.13],0.1107048743800315
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22990,1825,1.02 [0.94-1.12],0.5919124906131618
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25234,1093,1.11 [1.00-1.24],0.0520104189056128
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21282,117,1.18 [0.85-1.63],0.3203158247127585
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21500,335,1.04 [0.85-1.27],0.6818059728572123
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27304,111,1.17 [0.84-1.63],0.346735030115015
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27320,99,1.20 [0.85-1.70],0.3072360070537842
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21808,643,1.01 [0.87-1.16],0.9439023739382776
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",24356,643,1.00 [0.87-1.16],0.9760166455298506
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21208,43,1.13 [0.66-1.93],0.6515999544399831
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27253,42,1.13 [0.66-1.96],0.6551216237092985
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,21315,150,1.01 [0.75-1.36],0.9572481046914522
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21189,24,1.14 [0.56-2.32],0.7094016898643869
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21288,123,1.01 [0.73-1.40],0.9380166260399608
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27526,60,0.90 [0.56-1.45],0.6745533562597497
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,21487,322,0.98 [0.80-1.20],0.8565214829268298
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21382,217,0.98 [0.76-1.26],0.8629391757929481
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,22378,1213,1.03 [0.93-1.14],0.6041292555003489
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21200,35,1.00 [0.55-1.83],0.9999872688160784
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21333,168,0.93 [0.71-1.24],0.63942093154626
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21200,35,1.78 [1.08-2.94],0.0246112358501134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21192,27,0.78 [0.38-1.60],0.4949319162721147
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,21681,516,0.98 [0.83-1.15],0.7672174359242463
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,21593,428,1.03 [0.86-1.22],0.7657641556961015
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21884,277,1.10 [0.88-1.36],0.4028405564353413
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27251,151,1.01 [0.75-1.35],0.9654170821241312
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27139,39,0.92 [0.51-1.66],0.7751835837252257
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24720,49,0.82 [0.48-1.40],0.4623031450051911
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24885,214,1.01 [0.79-1.30],0.9165338043003672
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,25555,884,0.99 [0.88-1.12],0.9118864833595278
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24805,134,1.19 [0.88-1.60],0.2567347072707103
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24726,55,0.76 [0.46-1.27],0.2937882713484392
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25415,744,1.02 [0.89-1.17],0.7724844835557342
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24729,58,1.09 [0.69-1.74],0.7019549163916687
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24914,243,1.21 [0.97-1.51],0.0855009302986024
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24780,109,1.25 [0.90-1.73],0.1847854881048635
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24738,67,1.01 [0.65-1.57],0.956177242628296
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24817,146,0.85 [0.63-1.16],0.3076937469806131
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24735,64,1.18 [0.76-1.82],0.4649438136636713
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24988,317,1.18 [0.97-1.43],0.1034622707713441
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24427,286,1.14 [0.93-1.41],0.217122493720118
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24195,54,1.14 [0.71-1.84],0.5913843451298699
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24195,54,1.23 [0.77-1.97],0.3848579103322039
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24257,116,1.22 [0.89-1.68],0.2211199029737672
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24197,56,1.40 [0.90-2.18],0.1338207433011435
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24203,62,1.87 [1.29-2.72],0.001048160191213
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24189,48,1.72 [1.11-2.66],0.0144064398108309
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24365,224,0.90 [0.70-1.16],0.4136390918758112
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24192,51,0.83 [0.49-1.41],0.4990303197105459
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24196,55,1.09 [0.67-1.76],0.7390736658769008
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24249,108,0.82 [0.57-1.17],0.2714095425380013
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24213,72,0.64 [0.41-1.02],0.0587890249573471
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24564,423,1.09 [0.92-1.30],0.3353460362989552
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24285,144,0.89 [0.65-1.21],0.4418473057710951
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24357,216,1.20 [0.95-1.52],0.1339282054046839
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26274,97,1.07 [0.75-1.54],0.6984989735698055
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26512,335,1.03 [0.85-1.25],0.7741711014006192
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26232,55,1.00 [0.62-1.64],0.985024267321316
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26246,69,1.07 [0.70-1.64],0.767139297291184
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26292,115,0.94 [0.67-1.32],0.7065566057597569
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23345,4326,0.96 [0.90-1.02],0.2073000145065606
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11187,407,0.99 [0.83-1.19],0.9347225205055022
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26131,207,1.11 [0.86-1.41],0.4247785810844577
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25978,54,1.08 [0.66-1.75],0.7676622220304803
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26279,43,1.40 [0.84-2.32],0.1961516565174872
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26284,48,1.44 [0.89-2.32],0.1401221666931429
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26290,54,1.11 [0.69-1.79],0.6596609382946316
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27260,232,1.18 [0.94-1.48],0.1580297294982506
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27334,51,0.94 [0.56-1.56],0.7990718121920577
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27190,162,1.22 [0.93-1.60],0.1582540425386923
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27119,91,1.33 [0.93-1.89],0.1186100593064995
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26127,863,1.00 [0.89-1.14],0.938528393892152
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cystitis,25342,78,1.03 [0.69-1.55],0.8714074699251526
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25331,67,1.02 [0.66-1.59],0.9147374985994106
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25440,176,1.31 [1.01-1.69],0.0418883921756431
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25350,86,1.18 [0.81-1.72],0.3970639219483939
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25871,607,1.01 [0.87-1.17],0.9465769121898652
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10849,69,1.18 [0.78-1.78],0.4323489382271185
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),10816,36,0.92 [0.50-1.68],0.7771351859247866
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydrocele,10818,38,0.83 [0.46-1.52],0.5468827634259599
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",10873,93,1.18 [0.83-1.69],0.3551357414042078
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,10847,67,1.01 [0.65-1.57],0.9528717348699552
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,10881,101,0.72 [0.49-1.05],0.0888151485678551
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15108,246,1.27 [1.02-1.59],0.0355270886278732
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,14933,71,1.40 [0.93-2.09],0.1048766412925166
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,14951,89,1.20 [0.82-1.75],0.3498609890198174
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,14915,53,1.28 [0.79-2.06],0.3132022947945926
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15076,381,1.00 [0.82-1.20],0.9629212192264576
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,14776,81,0.82 [0.54-1.24],0.3467402203599976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14883,188,1.05 [0.80-1.37],0.7179598018365352
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,13893,2735,0.99 [0.92-1.07],0.8213677508209953
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Endometriosis,11454,296,1.11 [0.89-1.37],0.3544274266073052
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11249,91,1.25 [0.86-1.82],0.2410568929131881
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11271,113,1.12 [0.80-1.58],0.5126585806227872
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11459,301,1.03 [0.83-1.28],0.7966638763032904
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11461,303,0.94 [0.76-1.17],0.605443335582073
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11624,466,0.93 [0.78-1.11],0.4485385697500436
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11320,162,1.12 [0.84-1.49],0.4442450361138276
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11375,217,1.02 [0.80-1.31],0.8638922865608032
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11236,78,1.02 [0.67-1.55],0.9256208043172806
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11296,138,1.28 [0.94-1.74],0.1160716747109306
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15261,198,1.36 [1.06-1.74],0.0157145737558801
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15269,189,1.36 [1.06-1.75],0.0161882750816019
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15288,109,1.53 [1.11-2.10],0.0098987241057208
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15281,119,1.50 [1.10-2.04],0.0100905925315176
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11230,72,1.10 [0.72-1.70],0.6521841986679588
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11220,62,0.87 [0.54-1.41],0.5765146986091441
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11233,75,1.05 [0.68-1.61],0.8198367834126452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Irregular menses,15185,374,1.10 [0.91-1.32],0.3392610576225496
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12285,1127,1.02 [0.91-1.14],0.7903792904725879
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11929,771,0.97 [0.84-1.11],0.6196995274620043
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15268,155,0.95 [0.70-1.28],0.7277204844732417
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11507,349,0.82 [0.67-1.01],0.0676190057524946
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11436,278,0.85 [0.68-1.07],0.1679844464122172
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11419,261,1.04 [0.83-1.32],0.7184290705095914
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Female infertility,11273,115,1.10 [0.77-1.55],0.6068655323954499
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11266,108,1.08 [0.75-1.54],0.6853637168539042
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15281,863,0.85 [0.74-0.98],0.0265736953412033
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15287,1171,0.85 [0.75-0.96],0.0097421220313169
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15283,462,1.01 [0.85-1.21],0.8709862740534247
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,14952,131,0.91 [0.65-1.27],0.5701733066739572
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15009,188,0.86 [0.65-1.14],0.2927033253078067
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,14976,155,1.25 [0.94-1.68],0.1305242123787069
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15301,164,0.65 [0.48-0.89],0.0076203718064788
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15303,161,0.64 [0.47-0.88],0.0056452771277211
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15298,405,0.76 [0.62-0.93],0.0075504789398137
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15011,118,0.48 [0.33-0.71],0.000184435645899
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15120,227,0.82 [0.63-1.06],0.1271967606209925
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,14563,145,0.95 [0.69-1.31],0.7624152017625361
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,14614,196,0.78 [0.59-1.04],0.0930932666529593
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,14666,248,0.84 [0.65-1.08],0.1726867206538661
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,14562,144,0.89 [0.64-1.23],0.4656162484883246
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,14553,135,0.91 [0.65-1.27],0.5854959384675813
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,14567,149,0.67 [0.48-0.93],0.0178106357234574
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14343,227,0.82 [0.63-1.07],0.1489284522742482
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],14539,423,0.78 [0.64-0.95],0.0152128851190413
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,14766,650,0.83 [0.71-0.98],0.0297972314578585
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15304,165,1.01 [0.75-1.36],0.9485506788126
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,13876,126,0.89 [0.64-1.26],0.5201176463925752
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14215,99,0.92 [0.63-1.36],0.6871927855288031
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15311,332,0.76 [0.61-0.95],0.014790761745659
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15230,251,0.67 [0.52-0.87],0.0023471571852141
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15298,247,0.97 [0.76-1.23],0.7845245641258664
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15289,238,0.99 [0.77-1.27],0.931783835122131
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27392,34,1.22 [0.68-2.19],0.5101019148186403
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26004,513,0.92 [0.78-1.09],0.3374080081211266
